Surgical management of colorectal cancer metastases to the liver: multimodality approach and a single institutional experience

By Blackham Aaron U   Swett Katrina   Levine Edward A   Shen Perry  

Colorectal Cancer, Vol. 2, Iss. 1, 2013-02 ,pp. : 73-88

Future Medicine

Access to resources Recommend Favorite

Prognostic value of the BRAF V600E mutation in papillary thyroid carcinoma

By He Guoping   Zhao Baojian   Zhang Xu   Gong Rixiang  

Oncology Letters, Vol. 7, Iss. 2, 2014-02 ,pp. : 439-443

Spandidos Publications

Access to resources Recommend Favorite

Intratumor heterogeneity of BRAF V600E mutation in lung adenocarcinomas

By                  

Experimental and Therapeutic Medicine, Vol. 9, Iss. 5, 2015-01 ,pp. : 1719-1722

Spandidos Publications

Access to resources Recommend Favorite

A randomised phase II study of oxaliplatin alone versus oxaliplatin combined with 5-fluorouracil and folinic acid (Mayo Clinic regimen) in previously untreated metastatic colorectal cancer patients

By Zori Comba A.   Blajman C.   Richardet E.   Bella S.   Vilanova M.   Coppola F.   Van Kooten M.   Rodger J.   Giglio R.   Balbiani L.   Perazzo F.   Montiel M.   Chacon M.   Pujol F.   Mickiewicz E.   Cazap E.   Recondo G.   Lastiri F.   Simon J.   Wasserman E.   Schmilovich A.  

European Journal of Cancer, Vol. 37, Iss. 8, 2001-05 ,pp. : 1006-1013

Elsevier

Access to resources Recommend Favorite

Usefulness of immunohistochemistry for the detection of the BRAF V600E mutation in ovarian serous borderline tumors

By                  

Oncology Reports, Vol. 32, Iss. 5, 2014-01 ,pp. : 1815-1819

Spandidos Publications

Access to resources Recommend Favorite